Sternkopf, Marieke; Nagy, Magdolna; Baaten, Constance C F M J; Kuijpers, Marijke J E; Tullemans, Bibian M E; Wirth, Julia; Theelen, Wendy; Mastenbroek, Tom G; Lehrke, Michael; Winnerling, Benjamin; Baerts, Lesley; Marx, Nikolaus; De Meester, Ingrid; Döring, Yvonne; Cosemans, Judith M E M; Daiber, Andreas; Steven, Sebastian; Jankowski, Joachim; Heemskerk, Johan W M and Noels, Heidi (2020). Native, Intact Glucagon-Like Peptide-1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions. Arteriosclerosis, thrombosis, and vascular biology, 40(3), e65-e77. American Heart Association 10.1161/ATVBAHA.119.313645
Text
Unbenannt.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (2MB) |
OBJECTIVE
In patients with diabetes mellitus, increased platelet reactivity predicts cardiac events. Limited evidence suggests that DPP-4 (dipeptidyl peptidase 4) influences platelets via GLP-1 (glucagon-like peptide 1)-dependent effects. Because DPP-4 inhibitors are frequently used in diabetes mellitus to improve the GLP-1-regulated glucose metabolism, we characterized the role of DPP-4 inhibition and of native intact versus DPP-4-cleaved GLP-1 on flow-dependent thrombus formation in mouse and human blood. Approach and Results: An ex vivo whole blood microfluidics model was applied to approach in vivo thrombosis and study collagen-dependent platelet adhesion, activation, and thrombus formation under shear-flow conditions by multiparameter analyses. In mice, in vivo inhibition or genetic deficiency of DPP-4 (Dpp4-/-), but not of GLP-1-receptors (Glp1r-/-), suppressed flow-dependent platelet aggregation. In human blood, GLP-1(7-36), but not DPP-4-cleaved GLP-1(9-36), reduced thrombus volume by 32% and impaired whole blood thrombus formation at both low/venous and high/arterial wall-shear rates. These effects were enforced on ADP costimulation and occurred independently of plasma factors and leukocytes. Human platelets did not contain detectable levels of GLP-1-receptor transcripts. Also, GLP-1(7-36) did not inhibit collagen-induced aggregation under conditions of stirring or stasis of platelets, pointing to a marked flow-dependent role.
CONCLUSIONS
Native, intact GLP-1 is a natural suppressor of thrombus growth under physiological flow conditions, with DPP-4 inhibition and increased intact GLP-1 suppressing platelet aggregation under flow without a main relevance of GLP-1-receptor on platelets.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Angiology |
UniBE Contributor: |
Döring, Yvonne |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1079-5642 |
Publisher: |
American Heart Association |
Language: |
English |
Submitter: |
Isabel Lorenz |
Date Deposited: |
29 Jan 2020 09:23 |
Last Modified: |
05 Dec 2022 15:35 |
Publisher DOI: |
10.1161/ATVBAHA.119.313645 |
PubMed ID: |
31893947 |
Uncontrolled Keywords: |
diabetes mellitus glucagon-like peptide 1 glucose metabolism thrombosis |
BORIS DOI: |
10.7892/boris.138056 |
URI: |
https://boris.unibe.ch/id/eprint/138056 |